Publications

Export 117 results:
Sort by: [ Author (Asc)] Title Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G [H] I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
H
Habib FK, Ross M, Ho CK, Lyons V, Chapman K. Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression. International journal of cancer. Journal international du cancer. 2005;114:190-4. Abstract
Habib FK, Ross M, Bayne CW, Bollina P, Grigor K, Chapman K. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003;9:1815-9. Abstract
Hadoke PW. Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle. Pharmacology & therapeutics. 2001;89:233-54. Abstract
Hadoke PW, Iqbal J, Walker BR. Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British journal of pharmacology. 2009;156:689-712. Abstract
Hadoke PW, Christy C, Kotelevtsev YV, Williams BC, Kenyon CJ, Seckl JR, et al. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation. 2001;104:2832-7. Abstract
Hadoke PW, McIntyre CA, Gray GA, Buckley CH. Functional heterogeneity of large and small resistance arteries isolated from biopsies of subcutaneous fat: implications for investigation of vascular pathophysiology. Gen Pharmacol. 2000;35(3):119-27. Abstract
Hadoke PW, Lindsay RS, Seckl JR, Walker BR, Kenyon CJ. Altered vascular contractility in adult female rats with hypertension programmed by prenatal glucocorticoid exposure. The Journal of endocrinology. 2006;188:435-42. Abstract
Hadoke PW. Is endothelial progenitor cell senescence a therapeutic target in hypertension? J Hypertens. 2010;28(5):887-8.
Hadoke PW, Macdonald L, Logie JJ, Small GR, Dover AR, Walker BR. Intra-vascular glucocorticoid metabolism as a modulator of vascular structure and function. Cellular and molecular life sciences : CMLS. 2006;63:565-78. Abstract
Haga K, Murray S, Reid J, Ness A, O'Donnell M, Yellowlees D, et al. Identifying community based chronic heart failure patients in the last year of life: a comparison of the Gold Standards Framework Prognostic Indicator Guide and the Seattle Heart Failure Model. Heart. 2012;98(7):579-83. Abstract
Hainault I, Nebout G, Turban S, Ardouin B, Ferré P, Quignard-Boulangé A. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab. 2002;282(1):E59-66. Abstract
Hajduch E*, Turban S*, Le Liepvre X, Le Lay S, Lipina C, Dimopoulos N, et al. Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide. Biochem J. 2008;410(2):369-79. Abstract
Hajduch E, Litherland GJ, Turban S, Brot-Laroche E, Hundal HS. Insulin regulates the expression of the GLUT5 transporter in L6 skeletal muscle cells. FEBS Lett. 2003;549(1-3):77-82. Abstract
Hall RJ, Shenkin SD, MacLullich AM. A systematic literature review of cerebrospinal fluid biomarkers in delirium. Dement Geriatr Cogn Disord. 2011;32(2):79-93. Abstract
Hammer M, Lammert M, Mejías SM, Kern W, Frier BM. Costs of managing severe hypoglycaemia in three European countries. J Med Econ. 2009;12(4):281-90. Abstract
Hammer SJ, Dineley J, Easson WJ, Hoskins PR. An arterial wall motion test phantom for the evaluation of wall motion software. Ultrasound Med Biol. 2007;33(9):1504-11. Abstract
Hankey GJ, Hacke W, Easton DJ, Johnston CS, Mas J-, Brennan DM, et al. Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial. Stroke. 2010;41(8):1679-83. Abstract
Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet neurology. 2012. Abstract
Hankey GJ, Johnston CS, Easton DJ, Hacke W, Mas J-, Brennan D, et al. Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke. 2011;6(1):3-9. Abstract
Harding SA, Din JN, Sarma J, Jessop A, Weatherall M, Fox KA, et al. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thrombosis and haemostasis. 2007;98:451-6. Abstract
Harding SA, Sarma J, Josephs DH, Cruden NL, Din JN, Twomey PJ, et al. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation. 2004;109(16):1926-9. Abstract
Hardman D, Semple SI, Richards JM, Hoskins PR. Comparison of patient-specific inlet boundary conditions in the numerical modelling of blood flow in abdominal aortic aneurysm disease. Int j numer method biomed eng. 2013;29(2):165-78. Abstract
Harmar AJ, Sheward JW, Morrison CF, Waser B, Gugger M, Reubi JC. Distribution of the VPAC2 receptor in peripheral tissues of the mouse. Endocrinology. 2004;145:1203-10. Abstract
Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman PO, Dunbar DR, et al. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic acids research. 2009;37:D680-5. Abstract
Harmar AJ. What therapeutic opportunities are afforded by increasing our understanding of central and peripheral clocks? Dialogues in Cardiovascular Medicine. 2010;15(1):36-42. Abstract